HBsAg-话题@MedSci

#HBsAg#

29篇内容 | 2566人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2237343, encodeId=09e0223e343be, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, objectType=article, longId=850137, objectId=537285013e3b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=537285013e3b, replyNumber=0, likeNumber=7, createdTime=2024-11-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=537285013e3b, moduleTitle=【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=537285013e3b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2236579, encodeId=3ea022365e917, content=<a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=陈新月教授：非活动性HBsAg携带人群的诊疗进展, objectType=article, longId=849662, objectId=e3f88496629a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=e3f88496629a, replyNumber=0, likeNumber=15, createdTime=2024-11-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e3f88496629a, moduleTitle=陈新月教授：非活动性HBsAg携带人群的诊疗进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3f88496629a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2234368, encodeId=da07223436876, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=7dd51e788b8' target=_blank style='color:#2F92EE;'>#Treg细胞#</a> <a href='/topic/show?id=4efc120614f7' target=_blank style='color:#2F92EE;'>#AASLD2024#</a>, objectTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, objectType=article, longId=849225, objectId=290484922582, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240623/1719152329615_5579292.png, objectUrl=/article/show_article.do?id=290484922582, replyNumber=0, likeNumber=23, createdTime=2024-10-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=290484922582, moduleTitle=【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=290484922582)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2233438, encodeId=cbca2233438db, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=71af120514a2' target=_blank style='color:#2F92EE;'>#AASLD 2024#</a>, objectTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, objectType=article, longId=848852, objectId=feef8488524d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401026/1729954243486_8538692.png, objectUrl=/article/show_article.do?id=feef8488524d, replyNumber=0, likeNumber=27, createdTime=2024-10-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=feef8488524d, moduleTitle=【AASLD2024速递】提高HBsAg清除持久性的策略研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=feef8488524d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231744, encodeId=f3272231e44af, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a>, objectTitle=【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型, objectType=article, longId=847767, objectId=0eab84e7678f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=0eab84e7678f, replyNumber=0, likeNumber=27, createdTime=2024-10-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0eab84e7678f, moduleTitle=【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0eab84e7678f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2231347, encodeId=5470223134e2e, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型, objectType=article, longId=845307, objectId=424484530edd, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240607/1717775297944_5579292.jpg, objectUrl=/article/show_article.do?id=424484530edd, replyNumber=0, likeNumber=62, createdTime=2024-10-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=424484530edd, moduleTitle=【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=424484530edd)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2229999, encodeId=5f9022299994a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=998699e63f' target=_blank style='color:#2F92EE;'>#IP-10#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=b6cd1199e3e6' target=_blank style='color:#2F92EE;'>#PegIFN-α#</a>, objectTitle=【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关, objectType=article, longId=844209, objectId=4dc08442096d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719489899523_2570354.png, objectUrl=/article/show_article.do?id=4dc08442096d, replyNumber=0, likeNumber=83, createdTime=2024-10-09, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4dc08442096d, moduleTitle=【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4dc08442096d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2228076, encodeId=25d622280e6fd, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=cb65813029a' target=_blank style='color:#2F92EE;'>#肝硬化#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关, objectType=article, longId=843584, objectId=b28f843584de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=b28f843584de, replyNumber=0, likeNumber=55, createdTime=2024-09-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b28f843584de, moduleTitle=【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b28f843584de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2227827, encodeId=a9e6222e827d3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a> <a href='/topic/show?id=5fcb113801f8' target=_blank style='color:#2F92EE;'>#HBsAb#</a>, objectTitle=【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈, objectType=article, longId=843317, objectId=4e3484331ee0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=4e3484331ee0, replyNumber=0, likeNumber=46, createdTime=2024-09-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4e3484331ee0, moduleTitle=【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4e3484331ee0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225075, encodeId=7af622250e57a, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a> <a href='/topic/show?id=018880e834b' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α-2b#</a>, objectTitle=【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%, objectType=article, longId=842010, objectId=66c18420107c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720278845035_5579292.jpg, objectUrl=/article/show_article.do?id=66c18420107c, replyNumber=0, likeNumber=53, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=66c18420107c, moduleTitle=【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=66c18420107c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2225073, encodeId=0e3922250e377, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, objectType=article, longId=841868, objectId=e85284186840, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=e85284186840, replyNumber=0, likeNumber=53, createdTime=2024-09-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e85284186840, moduleTitle=【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e85284186840)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2224216, encodeId=546d222421682, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增, objectType=article, longId=841094, objectId=2acd8410948c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=2acd8410948c, replyNumber=0, likeNumber=61, createdTime=2024-09-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2acd8410948c, moduleTitle=【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2acd8410948c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223435, encodeId=395d222343517, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换, objectType=article, longId=840942, objectId=4d2b8409420b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240706/1720278845035_5579292.jpg, objectUrl=/article/show_article.do?id=4d2b8409420b, replyNumber=0, likeNumber=71, createdTime=2024-09-01, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=4d2b8409420b, moduleTitle=【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d2b8409420b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2223124, encodeId=22122223124a9, content=<a href='/topic/show?id=735a81364b7' target=_blank style='color:#2F92EE;'>#肝细胞癌#</a> <a href='/topic/show?id=678f5346e1e' target=_blank style='color:#2F92EE;'>#慢性乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点, objectType=article, longId=841065, objectId=b64084106599, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=b64084106599, replyNumber=0, likeNumber=66, createdTime=2024-08-29, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=b64084106599, moduleTitle=庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b64084106599)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222832, encodeId=2f9e22228321f, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=a7f5118451f6' target=_blank style='color:#2F92EE;'>#APASL 2024#</a> <a href='/topic/show?id=133411845256' target=_blank style='color:#2F92EE;'>#sPD-L1水平#</a>, objectTitle=【期刊导读】HBsAg清除预测新指标：sPD-L1水平, objectType=article, longId=840321, objectId=6b1c84032139, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240723/1721699880262_92910.jpg, objectUrl=/article/show_article.do?id=6b1c84032139, replyNumber=0, likeNumber=79, createdTime=2024-08-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b1c84032139, moduleTitle=【期刊导读】HBsAg清除预测新指标：sPD-L1水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b1c84032139)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2221714, encodeId=87302221e14d1, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=87e79848366' target=_blank style='color:#2F92EE;'>#隐匿性HBV感染#</a>, objectTitle=【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染, objectType=article, longId=839402, objectId=a8de83940258, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=a8de83940258, replyNumber=0, likeNumber=169, createdTime=2024-08-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a8de83940258, moduleTitle=【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a8de83940258)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2215446, encodeId=ce99221544675, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=f9d08524be' target=_blank style='color:#2F92EE;'>#HBV#</a>, objectTitle=【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短, objectType=article, longId=835003, objectId=8741835003ff, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716259408769_5579292.jpg, objectUrl=/article/show_article.do?id=8741835003ff, replyNumber=0, likeNumber=89, createdTime=2024-07-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=8741835003ff, moduleTitle=【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8741835003ff)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214927, encodeId=0b3e221492e50, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换, objectType=article, longId=834591, objectId=9480834591b1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719545882221_8538692.jpg, objectUrl=/article/show_article.do?id=9480834591b1, replyNumber=0, likeNumber=65, createdTime=2024-07-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=9480834591b1, moduleTitle=【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9480834591b1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2214408, encodeId=22ab2214408d3, content=<a href='/topic/show?id=370d8126914' target=_blank style='color:#2F92EE;'>#肝癌#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=b97885350d' target=_blank style='color:#2F92EE;'>#HBV感染#</a>, objectTitle=【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%, objectType=article, longId=830430, objectId=e08f8304309d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720664616921_5579292.png, objectUrl=/article/show_article.do?id=e08f8304309d, replyNumber=0, likeNumber=87, createdTime=2024-07-11, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e08f8304309d, moduleTitle=【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e08f8304309d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2213631, encodeId=1f2a2213631c2, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=19332343e64' target=_blank style='color:#2F92EE;'>#乙肝疫苗#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a>, objectTitle=【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率, objectType=article, longId=829998, objectId=727b8299981e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240705/1720155008578_5579292.jpg, objectUrl=/article/show_article.do?id=727b8299981e, replyNumber=0, likeNumber=79, createdTime=2024-07-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=727b8299981e, moduleTitle=【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=727b8299981e)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #AASLD2024#

【AASLD2024速递】RCT研究：非活动性HBsAg携带状态人群基于聚乙二醇干扰素α治疗48周的HBsAg清除率近40%

2024-11-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝# #HBsAg#

陈新月教授：非活动性HBsAg携带人群的诊疗进展

2024-11-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #Treg细胞# #AASLD2024#

【AASLD2024速递】Treg细胞可预测PegIFNα-2b治疗的HBsAg清除

2024-10-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #AASLD 2024#

【AASLD2024速递】提高HBsAg清除持久性的策略研究

2024-10-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #聚乙二醇干扰素α-2b#

【AASLD2024速递】聚乙二醇干扰素α-2b治疗获得HBsAg清除的疗程预测：基于基线HBsAg水平建立的简单模型

2024-10-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】预测获得HBsAg清除的慢乙肝患者肝脏相关不良结局风险的机器学习新模型

2024-10-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #IP-10# #慢乙肝# #PegIFN-α#

【期刊导读】慢乙肝患者治疗早期血清IP-10水平与HBsAg应答情况相关

2024-10-09发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #肝硬化# #HBsAg# #HBV#

【期刊导读】系统综述：慢性HBV感染者的HBsAg水平与肝硬化和肝癌风险显著相关

2024-09-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝# #HBsAb#

【临床治愈集结号】HBsAg和HBsAb双阳性的不确定期慢乙肝患者经延长治疗终获临床治愈

2024-09-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #HBV# #聚乙二醇干扰素α-2b#

【期刊导读】慢性HBV感染女性产后采用基于聚乙二醇干扰素α-2b治疗48周的HBsAg清除率达50%

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】合并脂肪肝的HBeAg阴性不确定期慢乙肝患者采用间歇治疗策略获HBsAg血清学转换

2024-09-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #慢乙肝#

【期刊导读】系统综述与网状荟萃分析：聚乙二醇干扰素α停药后的HBsAg清除率随观察时间递增

2024-09-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2024】长期核苷治疗的HBeAg阳性慢乙肝患者通过个体化间歇治疗策略获HBsAg血清学转换

2024-09-01发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝细胞癌# #慢性乙肝# #HBsAg#

庄辉院士权威解读：慢性乙肝患者HBsAg清除后，HCC监测关键要点

2024-08-29发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #APASL 2024# #sPD-L1水平#

【期刊导读】HBsAg清除预测新指标：sPD-L1水平

2024-08-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #隐匿性HBV感染#

【期刊导读】HBV S区突变导致的HBsAg检测不到可能形成隐匿性HBV感染

2024-08-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #HBV#

【期刊导读】HBsAg高水平的HBV相关肝癌患者术后无复发生存期更短

2024-07-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α# #慢乙肝#

【临床治愈集结号】HBsAg高水平的HBeAg阳性慢乙肝母女经基于聚乙二醇干扰素α的治疗同获HBsAg血清学转换

2024-07-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#肝癌# #HBsAg# #HBV感染#

【数据阅独】横断面调查：我国肝癌筛查目标人群的HBsAg阳性率为5.23%

2024-07-11发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #乙肝疫苗# #聚乙二醇干扰素α#

【期刊导读】经聚乙二醇干扰素α治疗获得HBsAg清除后联合乙肝疫苗可增强免疫应答，提高HBsAg血清学转换率

2024-07-06发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务